Key Highlights
- Lam Research (LRCX) reached a record peak of $274.42, marking a 262% gain over 12 months
- Third-quarter fiscal results exceeded Wall Street projections; fourth-quarter outlook also surpassed forecasts
- TD Cowen boosted its price objective to $340 from $290, keeping a Buy recommendation
- Multiple firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain bullish ratings
- Management revealed the firm has already surpassed its 2028 financial targets well ahead of schedule
Shares of Lam Research (LRCX) touched a fresh all-time peak of $274.42 during Thursday’s session, completing a remarkable 12-month rally that has seen the stock appreciate over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro shows the semiconductor equipment manufacturer has delivered a one-year return of 267%, with shares now trading within 1% of the 52-week peak of $273.50.
The impressive equity performance has been fueled by robust financial results and a wave of bullish analyst commentary in recent weeks.
Lam delivered third-quarter fiscal earnings that exceeded both Stifel’s projections and broader Street estimates. The company’s forward guidance for the fourth quarter also came in above analyst expectations for both top-line growth and profit margins.
Executives highlighted that the organization has already achieved its previously outlined financial model targets for calendar 2028 and beyond—well in advance of the original timeline.
Wall Street Increases Price Objectives
On Wednesday, TD Cowen’s Krish Sankar elevated his price target on LRCX shares to $340 from a prior $290, while reaffirming a Buy rating. Sankar acknowledged that skeptics may point to constrained upside potential following the robust June quarter guidance and elevated valuation multiples, but maintained that strong customer demand and solid profitability metrics justify continued upward estimate revisions.
Stifel similarly held its Buy rating while increasing its price objective to $325, emphasizing the company’s impressive quarterly performance.
RBC Capital Markets raised its target to $310, highlighting robust demand stemming from generative artificial intelligence applications and market share expansion, alongside an enhanced outlook for wafer fabrication equipment expenditures in 2026.
Cantor Fitzgerald maintained its Overweight rating with a $320 price target, emphasizing an improving outlook for wafer fab equipment spending extending through 2026 and 2027.
UBS confirmed its Buy rating, characterizing Lam’s current position as entering an AI-powered growth trajectory.
Strong Financial Foundation Supports Rally
Lam’s underlying financial metrics have remained solid throughout the stock’s ascent. The company boasts a flawless Piotroski Score of 9, indicating exceptional financial health, while 20 analysts have increased their earnings projections in recent months, according to InvestingPro data.
TD Cowen’s Sankar noted that bearish investors will likely argue that valuation multiples appear stretched following the strong guidance, but the firm maintains that robust customer demand and profitability trends continue to provide support.
LRCX shares finished Thursday’s session approximately 4% higher, resting close to the newly established all-time high of $274.42.
